Production (Stage)
Fresh Tracks Therapeutics, Inc.
FRTX
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -5.69M | -8.98M | -17.11M | -15.97M | -21.10M |
| Total Depreciation and Amortization | 41.00K | 40.00K | 37.00K | 33.00K | 30.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.98M | 2.22M | 1.89M | 2.05M | 2.22M |
| Change in Net Operating Assets | -669.00K | 929.00K | 2.05M | -398.00K | -478.00K |
| Cash from Operations | -4.34M | -5.80M | -13.13M | -14.28M | -19.34M |
| Capital Expenditure | -- | 0.00 | -47.00K | -47.00K | -47.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | -47.00K | -47.00K | -47.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.57M | 6.58M | 7.64M | 7.80M | 1.23M |
| Repurchase of Common Stock | -38.00K | -10.00K | 0.00 | 0.00 | -55.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.53M | 6.57M | 7.64M | 7.80M | 1.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.19M | 770.00K | -5.53M | -6.53M | -18.20M |